InsidersTradesSigma
Track the 헬릭스미스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 헬릭스미스 has logged 14 reports. Market capitalisation: €144.8bn. The latest transaction was disclosed on 4 May 2026 (Sale). Among the most active insiders: 김선영. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
Helixmith is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative therapies to treat serious diseases.